What is Cadence?
Cadence Solutions is a health technology company dedicated to enabling the nation's largest health systems to provide exceptional care beyond traditional hospital settings. Leveraging machine learning, the platform collects and analyzes patient vital signs to create personalized, real-time disease management strategies. This advanced approach offers unprecedented responsiveness in patient care, positioning Cadence Solutions at the forefront of digital health innovation.
How much funding has Cadence raised?
Cadence has raised a total of $241.9M across 4 funding rounds:
Angel/Seed
$874K
Series A
$41M
Series B
$100M
Series C
$100M
Angel/Seed (2018): $874K, investors not publicly disclosed
Series A (2021): $41M led by General Catalyst and Thrive Capital
Series B (2021): $100M supported by Thrive Capital, General Catalyst, and Coatue
Series C (2026): $100M featuring Spark Capital, Coatue, B Capital Group, Corewell Health Ventures, Memorial Hermann, Thrive Capital, Duke Health, and General Catalyst
Key Investors in Cadence
Spark Capital
Spark Capital is a venture capital firm known for investing in products by admired creators across various sectors, including Affirm, Coinbase, and Slack. They support founders across all stages and sectors from their offices in San Francisco, Boston, and New York City.
Coatue
Coatue Management is a global hedge fund sponsor that invests in public and private equity, as well as equity-related securities. Founded in 1999, the firm operates from New York City with additional offices in New Jersey and California.
B Capital Group
B Capital is a venture capital firm focused on empowering entrepreneurs in Technology, Healthcare, and Climate sectors. With a global presence and significant assets under management, they support companies throughout their lifecycle, from early to late stages.
What's next for Cadence?
The substantial enterprise-level funding and recent strategic investment indicate Cadence Solutions is poised for significant scaling and market expansion. This capital infusion will likely fuel further development of its machine learning capabilities, enhance its platform's reach across more health systems, and potentially support strategic partnerships or acquisitions. The company's focus on remote patient monitoring and data-driven care aligns with the growing demand for efficient and accessible healthcare solutions, suggesting a strong trajectory for future growth and impact in the health tech sector.
See full Cadence company page
